News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Vacci-Test Corporation Release: European Approval of VACCI-TEST(TM) Tetanus
June 10, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CALGARY, ALBERTA--(Marketwire - June 10, 2008) - Vacci-Test Corporation ("VTC") of Calgary, Alberta, Canada is pleased to announce that its subsidiary, Vacci-Test Europe, has received the CE mark for its first product, VACCI-TEST™ Tetanus.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
MORE ON THIS TOPIC
Insights
Historic ALS Investment Signals New Treatment Momentum
February 23, 2026
·
3 min read
·
Jennifer Smith-Parker
FDA
Makary, Prasad Under Fire as FDA Turmoil Reaches President Trump
February 20, 2026
·
6 min read
·
Heather McKenzie
Regulatory
FDA’s Top Drug Regulator To Probe Safety of Antidepressants, RSV Antibodies
February 20, 2026
·
2 min read
·
Tristan Manalac
Government
Cassidy Names Areas of Improvement for FDA’s Regulatory ‘Black Box’
February 19, 2026
·
3 min read
·
Tristan Manalac